Kepos Capital’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

Kepos Capital’s Portfolio PEARW Stock Details PEARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$25K	Hold	167,711	–	–	﹤0.01%	309
2022 Q3	$28K	Hold	167,711	–	–	﹤0.01%	339
2022 Q2	$26K	Sell	167,711 -82,289	-33%	-$40.7K	﹤0.01%	402
2022 Q1	$198K	Hold	250,000	–	–	0.01%	333
2021 Q4	$150K	Hold	250,000	–	–	0.01%	447
2021 Q3	$238K	Hold	250,000	–	–	0.02%	444
2021 Q2	$370K	Buy	+250,000	New	+$218K	0.03%	335

Other funds holding PEARW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

DCM

Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return

AGC

Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return

QGA

Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

SRF

Silver Rock Financial Los Angeles, California $49.7M AUM 17.42% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Kepos Capital's PEARW Position: Q4 2022 in Review

Kepos Capital held its Pear Therapeutics, Inc. Warrant (PEARW) position steady in Q4 2022 at 167,711 shares worth $25K. The position accounts for ﹤0.01% of the portfolio, ranked #309.

Kepos Capital first reported a position in PEARW in Q2 2021 and has held it in 7 quarters since. The position peaked at $370K in Q2 2021. 33 funds tracked by Wall St. Rank hold PEARW as of Q4 2022.

Kepos Capital held 167,711 shares of Pear Therapeutics, Inc. Warrant worth $25K as of Q4 2022.
Kepos Capital left its Pear Therapeutics, Inc. Warrant share count unchanged in Q4 2022.
Pear Therapeutics, Inc. Warrant made up ﹤0.01% of Kepos Capital's portfolio in Q4 2022, its #309 holding.
Kepos Capital first reported a position in Pear Therapeutics, Inc. Warrant in Q2 2021 and has held it in 7 quarters since.
Kepos Capital's Pear Therapeutics, Inc. Warrant position peaked at $370K in Q2 2021.
33 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q4 2022.

Based on Kepos Capital's 13F filing for Q4 2022, filed 13 Feb 2023.